Related Experiment Videos
Recurrent hemoperitoneum complicating continuous ambulatory peritoneal dialysis
Kai-Chung Tse1, Pok-Siu Yip, Man-Fei Lam
1Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
Summary
Recurrent hemoperitoneum in continuous ambulatory peritoneal dialysis (CAPD) patients is generally benign. This complication does not significantly impact patient survival, peritonitis risk, or ultrafiltration failure.
Area of Science:
- Nephrology
- Internal Medicine
- Dialysis
Background:
- Recurrent hemoperitoneum is a known complication of continuous ambulatory peritoneal dialysis (CAPD).
- Understanding its impact on patient outcomes is crucial for managing CAPD patients.
Purpose of the Study:
- To investigate the clinical features, outcomes, and peritoneal transport characteristics of CAPD patients experiencing recurrent hemoperitoneum.
- To assess the long-term effects of this complication on patient management and survival.
Main Methods:
- Retrospective case review of 549 CAPD patients over 10 years.
- Included 21 patients with two or more episodes of hemoperitoneum.
- Assessed demographic factors, etiology, clinical outcomes, and peritoneal equilibration tests (PET).
Main Results:
- 21 patients (3.8%) experienced recurrent hemoperitoneum, averaging 4.3 episodes each.
- Most common causes were retrograde menstruation (females) and unknown (males).
- No significant association found between hemoperitoneum episodes and peritonitis, clinical outcomes, or survival; no ultrafiltration failure observed.
Conclusions:
- Recurrent hemoperitoneum is a benign complication in CAPD.
- It does not appear to significantly affect patient survival, increase peritonitis risk, or lead to ultrafiltration failure.